Oncogene Cancer Research

Actions to Boost Lung Cancer Research and Innovation

Giannis Mountzios, Consultant Medical Oncologist of the 2nd Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a recent article by M.-L. Meyer on X:

“A strategic position statement in Annals of Oncology on the main actions to boost lung cancer research and innovation:  

  • Pragmatic trials  
  • Ensure inclusivity and diversity  
  • NGS in resectable NSCLC  
  • Exploit resistance mechanism
  • Focus on novel Tox”

Title: Lung cancer research and treatment: global perspectives and strategic calls to action

Authors: M.-L. Meyer, S. Peters, T.S. Mok, S. Lam, P.-C. Yang, C. Aggarwal, J. Brahmer, R. Dziadziuszko, E. Felip, A. Ferris, P.M. Forde, J. Gray, L. Gros, B. Halmos, R. Herbst, P.A. Jänne, B.E. Johnson, K. Kelly, N.B. Leighl, S. Liu and F.R. Hirsch

Lung Cancer

Lung Cancer

More posts featuring Giannis Mountzios.

Annals of Oncology B.E. Johnson C. Aggarwal cancer Cancer research F.R. Hirsch K. Kelly Lung cancer M.-L. Meyer N.B. Leighl NSCLC OncoDaily Oncology P.-C. Yang P.A. Janne Research S. Lam S. Liu S. Peters T.S. Mok